Last reviewed · How we verify

NCT05854888: PeMWaC

Perineal Massage and Warm Compresses - RCT for Reduce Perineal Trauma During Labor

Completed NA Last updated 11 May 2023
What this trial tests

NA trial testing Perineal Massage and Warm Compresses (PeMWaC) in Perineal Tear Resulting From Childbirth in 800 participants. Completed in 1 July 2021.

Timeline
1 March 2019
Primary endpoint
31 December 2020
1 July 2021

Quick facts

Lead sponsorUniversidade do Porto
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment800
Start date1 March 2019
Primary completion31 December 2020
Estimated completion1 July 2021
Sites1 location across Portugal

Drugs / interventions tested

Conditions studied

Sponsor

Universidade do Porto — full company profile →

Who can join

18 and older, female only, with Perineal Tear Resulting From Childbirth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the effect of a combined perineal massage and warm compresses intervention on the perineum integrity during second stage of labor.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of Perineal Massage and Warm Compresses Technique in Postpartum Pelvic Floor Dysfunction. A Secondary Analysis from a Randomised Controlled Trial.
    Rodrigues S, Silva P, Borges AC, de Sousa NQ, et al · · 2024 · PMID 38097899 · DOI 10.1007/s43032-023-01424-4

Verify or expand the search:

Other recruiting trials for Perineal Tear Resulting From Childbirth

Currently open trials in the same condition.

Other Universidade do Porto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05854888.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing